Related Experiment Videos
Phenobarbitone prophylaxis of intraventricular haemorrhage
Archives of Disease in Childhood
|February 1, 1986
Summary
Phenobarbitone treatment for preterm infants (under 1500 g) showed a lower incidence of intraventricular hemorrhage (IVH) and mortality compared to controls. This suggests phenobarbitone may be effective in preventing IVH in premature neonates.
Area of Science:
- Neonatology
- Pediatric Neurology
- Pharmacology
Background:
- Intraventricular hemorrhage (IVH) is a significant complication in preterm infants.
- Premature birth (<1500 g) increases the risk of neonatal brain injury, including IVH.
- Effective preventative strategies for IVH are crucial in neonatal care.
Purpose of the Study:
- To evaluate the efficacy of phenobarbitone in reducing the incidence of intraventricular hemorrhage (IVH) in very low birth weight preterm infants.
- To assess the impact of phenobarbitone on mortality rates in this vulnerable population.
Main Methods:
- A prospective study involving 30 preterm infants (birthweight <1500 g) treated with phenobarbitone.
- A control group of 28 preterm infants with similar birthweights was used for comparison.
- Incidence of IVH and mortality were recorded for both groups.
Main Results:
- The phenobarbitone-treated group exhibited a 57% incidence of IVH.
- The control group showed a higher IVH incidence of 68%.
- Mortality rates were 13% in the treated group and 14% in the control group.
Conclusions:
- Phenobarbitone treatment may reduce the incidence of intraventricular hemorrhage in preterm infants.
- The study suggests a potential benefit of phenobarbitone in improving outcomes for very low birth weight neonates.
- Further research is warranted to confirm these findings and optimize phenobarbitone use.